SCHEMBL19981533

SCHEMBL19981533

Cc1ccccc1-c1cnc(N)s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 2/20 0.55
BACE1 P56817 2/20 0.50
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
ALDH1A1 P00352 3/20 0.47
MAPT P10636 2/20 0.47
KDM4E B2RXH2 1/20 0.47
TP53 P04637 1/20 0.47
MAPK14 Q16539 3/20 0.46
NOS1 P29475 1/20 0.45
ALOX5AP P20292 1/20 0.42
FEN1 P39748 1/20 0.42
HPGD P15428 1/20 0.41
CSNK2A1 P68400 1/20 0.40
LCK P06239 1/20 0.40
KDR P35968 1/20 0.40
JAK3 P52333 1/20 0.40
CTSD P07339 1/20 0.38
NAMPT P43490 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL30271555 0.91 LIMK1 (0.48) LIMK1BACE1NPC1RAB9ASMN1; SMN2
SCHEMBL38544 0.81 LIMK1 (0.72) LIMK1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL30513213 0.81 LIMK1 (0.72) LIMK1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL21091358 0.81 HPGD (0.43) LIMK1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL11953304 0.81 LIMK1 (0.54) LIMK1BACE1NPC1RAB9ASMN1; SMN2
SCHEMBL15090515 0.79 HPGD (0.42) LIMK1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL3136303 0.79 BACE1 (0.51) LIMK1BACE1NPC1RAB9ASMN1; SMN2
SCHEMBL29993395 0.78 ALDH1A1 (0.53) LIMK1BACE1NPC1RAB9ASMN1; SMN2
SCHEMBL2404342 0.78 ALDH1A1 (0.53) LIMK1BACE1NPC1RAB9ASMN1; SMN2
SCHEMBL31063632 0.75 ALDH1A1 (0.51) LIMK1BACE1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630562-B2 Piperidylurea compounds and methods of use thereof ARCUS BIOSCIENCES, INC. (US) 2026-05-19 US disclosed
US-20260042777-A1 PIPERIDYLUREA COMPOUNDS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2026-02-12 US disclosed
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2023-03-07 US disclosed
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2021-07-22 US disclosed
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2021-07-22 US disclosed
CN-108699035-A Noval chemical compound 特殊治疗有限公司 2018-10-23 CN disclosed
WO-2018050656-A2 INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF HSF PHARMACEUTICALS (CH) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 LIMK1 1446/4885BACE1 4127/4885NPC1 3462/4885
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 LIMK1 1446/4885BACE1 4127/4885NPC1 3462/4885
US-12630562-B2 Piperidylurea compounds and methods of use thereof CLIC1, HCCS, CNR1 LIMK1 4659/4885BACE1 4115/4885NPC1 73/4885
US-20260042777-A1 PIPERIDYLUREA COMPOUNDS AND METHODS OF USE THEREOF CBR1, CLIC1, RER1 LIMK1 4625/4885BACE1 4301/4885NPC1 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.